Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses
As we round out our series on private equity investing in dialysis, we note an emergence in overseas dialysis investing by U.S. investors. Our blog typically focuses on U.S. investing but can’t help but note the interest in overseas…
Continue Reading Private Equity Investing in the Dialysis Sector – Part III (Overseas Investing)
Part II of our series on private equity investing in dialysis discusses other dialysis companies backed by private equity and highlights some key considerations for investors and companies.
Funded in 2000, U.S. Renal Care (USRC), is another dialysis company…
Continue Reading Private Equity Investing in the Dialysis Sector – Part II
The U.S. dialysis industry includes more than 4,000 outpatient dialysis facilities (in addition to a large number of home dialysis programs) that service more than 350,000 patients suffering from end stage renal disease (ESRD). The industry self-classifies dialysis companies as …
